← All stories
Startups by sector

18 new health tech startups in Europe worth knowing (2026)

Eighteen young European health tech startups with 2026 funding news, from drug discovery on living tissue and virtual patients for heart implants to home hormone tests and AI assistants for doctors: what they do, who founded them and a source for every fact.

Illustration of a lab flask with a tissue sample, a chip with a lens, a heart model, a pill, a phone with a stethoscope, a small test device, test tubes and a plaster on a long table
Illustration: Meet New Brands (AI-generated)

Some of the newest health tech startups in Europe in 2026 are Vitroscope, adsilico, Constellate Proteomics, Siloton, Unravel Health, Rivercell, Cori Clinical, Omnio, Breye Therapeutics, Flouria, Aptadir Therapeutics, Usawa Care, Tandem Health, Halmos Labs, OurMind, Lucis, Sedivention and Delphyr. They work on drug discovery from living tissue and virtual cells, virtual patients for testing implants, antibody and eye testing, new medicines for wounds, eye disease and genetic conditions, home hormone tests, online clinics for women and children, AI assistants that take paperwork off doctors, preventive blood tests and a one-time treatment for obesity, and each announced funding, a contract or a new investor this year. Most of them also appear in one of our city, country or weekly lists, with a source for every fact. This page is updated as new ones appear. Last updated: 4 November 2026.

Vitroscope (Trondheim): drug discovery data from living human tissue Profile

Vitroscope is a biotech company that develops perfusion platforms to study immune activity, treatment responses and disease mechanisms in living human tissue in real time; its benchtop platform vitro.alive keeps flow, oxygen, pH and temperature under control. Founded in 2019 by Carlo Kriesi (CEO) and Heikki Sjöman, it announced 7 million dollars on 3 November 2026: a 5 million dollar seed round co-led by Cerberus Ventures and YZR Capital, with Arcas Ventures, Golden Egg Check and Devico Invest, plus 2 million dollars in non-dilutive funding from the Research Council of Norway. Website: vitroscope.com. Sources: Tech.eu, The Hub.

adsilico (Leeds): testing medical devices on virtual patients Profile

adsilico, a University of Leeds spinout, makes Virtual Chimera, a platform that uses generative AI and physics-based simulations to model hearts and blood vessels, so device makers can assess how an implant performs before it goes into clinical trials. Founded in 2024 by Sheena Macpherson (CEO), Dr Nishant Ravikumar and Dr Zeike Taylor, it announced a 10 million pound Series A led by PXN Ventures, with existing investors Northern Gritstone and Parkwalk, on 26 October 2026. Website: adsilico.uk. Source: Tech.eu.

For foundersGet your startup featured for freeBuilding something new in Europe? We write a free article about it. Sharing it on LinkedIn is welcome, never required.Pitch your startup →

Constellate Proteomics (Delft): antibody quality checks in minutes instead of weeks Profile

Constellate Proteomics develops RAYmAb, a platform that runs four antibody quality checks (titre, glycosylation, aggregation and charge variants) on a small, untreated sample in minutes, where current methods take weeks of specialised work; it is aimed at biotech, pharma and contract manufacturing teams that develop antibody drugs. It was spun out of TU Delft in February 2026 by Carlos de Lannoy (CEO), Arian Khoshchin and Dennis de Beeld. IO+ reported on 21 October 2026 that it raised a 150,000 euro pre-seed round in convertible financing from Tech Scout Venture Fund and Imec.istart. Website: constellate.pro. Source: IO+. Also in our list: New startups in the Netherlands (2026).

Siloton (Bristol): eye scans from a photonic chip Profile

Siloton, from Bristol, makes miniaturised optical imaging technology: photonic chips and optical coherence tomography (OCT) systems that help detect and monitor eye conditions such as macular degeneration and glaucoma. Founded in 2020 and led by CEO Alasdair Price, it announced on 19 October 2026 that it won an 8.4 million pound (about 9.98 million euro) contract from Innovate UK, under the Contracts for Innovation: Quantum Missions Primer programme, to develop its handheld eye imaging system. Website: siloton.com. Source: EU-Startups. Also in our list: Five new European startups to know, 13 to 20 October 2026.

Unravel Health (London): a palm-sized hormone lab for the home Profile

Unravel Health, from London, is a women's health startup developing the Micro Lab, a palm-sized device that reads several hormones from a saliva sample in minutes, so women can track their hormones at home. Founded in 2024 by Veronika Bridgman (CEO), Liza Levy and Dr Alexandra Oti, it announced a 2.5 million pound (about 2.96 million euro) round on 16 October 2026, led by Conduit EIS Impact Fund and Wrightwood, with Leo Capital, Embryo Ventures, Hermesa and returning investor Zinc VC. Website: unravel.health. Source: EU-Startups. Also in our list: Five new European startups to know, 13 to 20 October 2026.

Rivercell (Paris): a virtual cell for drug discovery Profile

Rivercell, from Paris, combines its own lab data on how human cells respond to drugs and genetic changes with an AI model of the cell, so researchers can predict results before running costly wet-lab experiments. Founded in 2026 and led by co-founder and CEO Yann Fleureau, it came out of stealth on 7 October 2026 with a 22 million euro seed round led by HV, with HCVC, Alven and Bpifrance Digital Venture. Website: rivercell.ai. Source: EU-Startups. Also in our list: European startups that raised money in October 2026.

Cori Clinical (London): spotting clinical trial delays before they happen Profile

Cori Clinical, from London, acts as an intelligence layer for clinical trials, so teams can spot avoidable delays before they happen. Founded in 2025, it closed a 3.8 million euro seed round led by Breega, reported on 7 October 2026. Website: cori-clinical.com. Source: EU-Startups. Also in our list: European startups that raised money in October 2026.

Omnio (Umeå): a new treatment for wounds that will not heal Profile

Omnio develops a plasminogen-based treatment for chronic wounds such as diabetic foot ulcers, based on research at Umeå University. Led by CEO Felipe Velasquez, it announced a 2.9 million euro round from existing investors on 2 October 2026 and plans clinical trials in 2027. Website: omnio.se. Source: EU-Startups. Also in our list: New startups in Sweden (2026).

Breye Therapeutics (Denmark): a pill for early diabetic eye disease Profile

Breye Therapeutics, from Denmark, develops oral medicines for early-stage retinal diseases, starting with diabetic retinopathy. Founded in 2019 and led by CEO Ulrik Mouritzen, it announced an oversubscribed 67.5 million euro Series A led by Mission BioCapital and Novo Holdings on 2 October 2026, to take its lead candidate into Phase 2 trials planned for 2027. Website: breye.com. Source: EU-Startups. Also in our list: European startups that raised money, 28 September to 2 October 2026.

Flouria (Amsterdam): an online clinic for women's hormonal health Profile

Flouria, from Amsterdam, runs a digital clinic with doctor-led care for women with hormonal conditions such as perimenopause, PCOS and postpartum recovery, including testing, tracking and a personal treatment plan. It was co-founded by Jeanine van Munster, Vlatko Stojovski and Anna Christie, launched in October 2025 and says it has served more than 1,000 women in the Netherlands. On 1 October 2026 it announced that Healthy.Capital had joined its 1.5 million euro funding, to grow in the Netherlands and expand to other European countries. Website: flouria.health. Source: Flouria press release. Also in our list: Five new European startups to know, 29 September to 6 October 2026.

Aptadir Therapeutics (Milan): RNA medicines for hard-to-treat genetic conditions Profile

Aptadir Therapeutics is developing a new class of RNA inhibitors that silence defective genes, starting with Fragile X Syndrome, and is at the preclinical stage. Founded in 2023 by Annalisa Di Ruscio, Daniel Tenen, Vittorio de Franciscis, Giovanni Amabile and Marcin Kortylewski, it announced a 45 million dollar seed round led by 4BIO Capital on 29 September 2026. Website: aptadir.com. Sources: Tech.eu, BeBeez. Also in our list: New startups in Milan (2026).

Usawa Care (Portugal): a paediatrician on WhatsApp Profile

Usawa Care is a digital paediatric clinic: families get unlimited consultations with a dedicated paediatrician over WhatsApp for 12 euro a month, with a free version with reduced hours. Founded and led by Luís Almeida Fernandes, a former director of the SNS24 health line, it said in September 2026 that it works with 23 paediatricians for more than 12,000 registered children, and announced a 3 million dollar seed round led by Armilar, with Start Ventures, Oxy Capital and angel investor Jorge Marques, to launch an adult service in October and start in the United States. Website: usawacare.com. Sources: Portugal Startup News, ECO. Also in our list: New startups in Portugal (2026).

Tandem Health (Stockholm): an AI assistant for doctors and clinics Profile

Tandem Health builds an AI medical assistant that supports clinicians during patient visits with documentation, coding and clinical decision support, for healthcare providers across Europe. Founded in 2023 by Lukas Saari, Oscar Boldt-Christmas and Oliver Åstrand, it announced a 100 million dollar (86.49 million euro) Series B led by the EQT-managed Scaleup Europe Fund on 14 September 2026. Website: tandemhealth.ai. Source: EU-Startups. Also in our list: New startups in Stockholm (2026).

Halmos Labs (Lund): automating biotech research Profile

Halmos Labs builds automated systems for biotech research, from planning lab experiments to manufacturing cancer vaccines. Founded by Mattias Akke and Linus von Ekensteen Löfgren, it announced 500,000 dollars in first funding as it joined Y Combinator's fall 2026 batch on 8 September 2026. Website: halmoslabs.com. Sources: Swedish Tech News, Öresund Startup News. Also in our list: New startups in Malmö and Lund (2026).

OurMind (Amsterdam): an AI assistant for doctors' paperwork Profile

OurMind builds a personal AI platform that helps GPs, medical specialists and hospitals with medical documentation, consultation preparation and other admin, to give doctors more time for patients. Founded in 2024 by Marco Ferraz, Paul Koning, Renan Sales Barros and Fredrik Gustafsson, it announced 2.1 million euro led by 4impact capital, with support from Invest-NL and the EU's InvestEU programme, on 11 June 2026. Website: ourmind.ai. Source: EU-Startups. Also in our list: New startups in Amsterdam (2026).

Lucis (Paris): preventive health from a blood test Profile

Lucis is a preventive health app that analyses more than 110 blood biomarkers and gives personal recommendations checked by doctors. Founded in 2025 by Maxime Berthelot (CEO) and Baptiste Debever and backed by Y Combinator, it announced a Series A of about 20 million dollars (roughly 17 million euro) led by Singular on 26 May 2026. Website: lucis.life. Source: EU-Startups. Also in our list: New startups in Paris (2026).

Sedivention (Munich): a one-time outpatient treatment for obesity Profile

Sedivention is developing a cryo-balloon catheter that freezes the nerve branches of the stomach that signal hunger, as a one-time outpatient treatment for obesity. Founded by Dr. Ute Nollert, Dr. Andreas Broecker and Andre Burch, it announced a 2.9 million euro seed round led by bmp Ventures with the IBG funds on 11 May 2026. Website: sedivention.com. Source: Munich Startup. Also in our list: New startups in Munich (2026).

Delphyr (Amsterdam): AI agents that take admin off doctors Profile

Delphyr builds AI agents for healthcare professionals in hospitals, primary care and mental health: it brings patient data together, finds clinical guidelines, drafts consultation notes and automates routine workflows. Founded in 2023 by Michel Abdel Malek, it announced 1.75 million euro from investors including founders of Hugging Face and DEGIRO on 3 March 2026. Website: delphyr.ai. Source: EU-Startups. Also in our list: New startups in Amsterdam (2026).

A founder story from a health startup

FysioAgent wants physiotherapists to spend less time behind the screen: a former physiotherapist from Breda built an AI scribe that listens during treatments and writes the notes, so the time goes to the patient instead of the keyboard.

Quick facts

  • Vitroscope (Trondheim): perfusion platforms for drug discovery from living human tissue, 5 million dollar seed plus 2 million dollars in non-dilutive funding (November 2026)
  • adsilico (Leeds): virtual patients for testing heart implants, 10 million pound Series A (October 2026)
  • Constellate Proteomics (Delft): antibody quality checks in minutes, 150,000 euro pre-seed (October 2026)
  • Siloton (Bristol): handheld eye imaging from a photonic chip, 8.4 million pound Innovate UK contract (October 2026)
  • Unravel Health (London): a palm-sized hormone lab for the home, 2.5 million pound round (October 2026)
  • Rivercell (Paris): a virtual cell for drug discovery, 22 million euro seed (October 2026)
  • Cori Clinical (London): an intelligence layer for clinical trials, 3.8 million euro seed (October 2026)
  • Omnio (Umeå): a plasminogen-based treatment for chronic wounds, 2.9 million euro (October 2026)
  • Breye Therapeutics (Denmark): oral medicines for early diabetic eye disease, 67.5 million euro Series A (October 2026)
  • Flouria (Amsterdam): an online clinic for women's hormonal health, Healthy.Capital joins its 1.5 million euro funding (October 2026)
  • Aptadir Therapeutics (Milan): RNA medicines for genetic conditions, 45 million dollar seed (September 2026)
  • Usawa Care (Portugal): a paediatrician on WhatsApp, 3 million dollar seed (September 2026)
  • Tandem Health (Stockholm): an AI medical assistant for clinicians, 100 million dollar Series B (September 2026)
  • Halmos Labs (Lund): automated biotech research, 500,000 dollars and Y Combinator (September 2026)
  • OurMind (Amsterdam): an AI assistant for doctors' paperwork, 2.1 million euro (June 2026)
  • Lucis (Paris): preventive health from a blood test, about 20 million dollar Series A (May 2026)
  • Sedivention (Munich): a one-time outpatient treatment for obesity, 2.9 million euro seed (May 2026)
  • Delphyr (Amsterdam): AI agents that take admin off doctors, 1.75 million euro (March 2026)

FAQ

What are new health tech startups in Europe in 2026? Young European health tech startups with news in 2026 include Vitroscope, adsilico, Constellate Proteomics, Siloton, Unravel Health, Rivercell, Cori Clinical, Omnio, Breye Therapeutics, Flouria, Aptadir Therapeutics, Usawa Care, Tandem Health, Halmos Labs, OurMind, Lucis, Sedivention and Delphyr. They range from drug discovery and medical devices to digital clinics and AI tools for doctors. This list is updated as new companies appear.

Which health startups on this list raised the most in 2026? Of the companies on this page, Tandem Health raised a 100 million dollar Series B, Breye Therapeutics a 67.5 million euro Series A, Aptadir Therapeutics a 45 million dollar seed round, Rivercell a 22 million euro seed round and Lucis a Series A of about 20 million dollars.

How does a health startup get on this list? We add young European health, medtech and biotech companies with a recent, publicly reported launch or funding round. Founders can also pitch their story for a free full article; sharing it on LinkedIn afterwards is welcome, never a condition. More lists: New climate tech startups in Europe (2026), New AI agent startups in Europe (2026), New startups in London (2026) and all our articles.

Building something new?Get your startup or brand featured for free. No fees and no conditions.
Pitch your story →

Featured in this story? Get your share kit: a ready LinkedIn post and a badge for your website.